BioCentury | Mar 20, 2014
Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Atherosclerosis Squalene synthase (SQS; FDFT1); cyclooxygenase (COX) In vitro and mouse studies suggest a new class of trifunctional, cholesterol-limiting, anti-inflammatory, antioxidant compounds could help...
BioCentury | May 23, 2011
Strategy

Takeda's global boost

Acquiring Nycomed will transform Takeda Pharmaceutical Co. Ltd. into a complete global pharma company by combining geographically complementary marketing operations. But the Japanese pharma will need more acquisitions to get its market cap back to...
Items per page:
1 - 2 of 2